Applied Therapeutics Ownership 2024 | Who Owns Applied Therapeutics Now?
Institutional Ownership
80.33%
Insider Ownership
5.31%
Retail Ownership
14.36%
Institutional Holders
91.00
Applied Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC | 8.15% | 0.01% | 10,212,945 | -351,400 | -3.33% | 47,694,453 | Jun 30, 2024 |
| VR ADVISER, LLC | 7.61% | 2.84% | 9,542,871 | 467,871 | 5.16% | 44,565,208 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 6.39% | 0.89% | 8,005,000 | - | - | 37,383,350 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 6.10% | 0.02% | 7,648,205 | 1,233,563 | 19.23% | 35,487,671 | Jun 30, 2024 |
| BLACKROCK INC. | 5.24% | 0.00% | 6,569,787 | 5,580,510 | 564.10% | 30,680,905 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 5.24% | 19.89% | 6,567,858 | 455,952 | 7.46% | 30,671,897 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 4.45% | 17.54% | 5,574,687 | - | - | 26,033,788 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 4.33% | 1.89% | 5,430,000 | 320,000 | 6.26% | 25,358,100 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.25% | 0.00% | 5,322,460 | 2,312,170 | 76.81% | 24,855,889 | Jun 30, 2024 |
| MORGAN STANLEY | 2.81% | 0.00% | 3,519,737 | 325,685 | 10.20% | 16,437,171 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 2.25% | 0.88% | 2,817,505 | - | - | 13,157,748 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.21% | 0.02% | 2,774,784 | 125,000 | 4.72% | 12,958,241 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.87% | 0.00% | 2,343,483 | 1,721,256 | 276.63% | 10,944,066 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.86% | 1.11% | 2,330,000 | 100,000 | 4.48% | 10,881,100 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.82% | 0.50% | 2,286,135 | 333,278 | 17.07% | 10,676,250 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.76% | 3.03% | 2,211,320 | 194,304 | 9.63% | 10,326,864 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.67% | 0.00% | 2,098,815 | 1,494,387 | 247.24% | 9,802,702 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 1.57% | 0.05% | 1,965,646 | 522,720 | 36.23% | 9,179,567 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.34% | 1.79% | 1,680,000 | -90,000 | -5.08% | 7,845,600 | Jun 30, 2024 |
| STATE STREET CORP | 1.32% | 0.00% | 1,655,883 | 1,449,214 | 701.22% | 7,732,974,000 | Jun 30, 2024 |
Applied Therapeutics's largest institutional shareholder is FRANKLIN RESOURCES INC, holding 8.15% of the company's total share outstanding, currently valued at $47.69M. The top 10 institutional shareholders own together 54.58% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROPEL BIO MANAGEMENT, LLC | 5.24% | 19.89% | 6,567,858 | 455,952 | 7.46% | 30,671,897 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 4.45% | 17.54% | 5,574,687 | - | - | 26,033,788 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.76% | 3.03% | 2,211,320 | 194,304 | 9.63% | 10,326,864 | Jun 30, 2024 |
| VR ADVISER, LLC | 7.61% | 2.84% | 9,542,871 | 467,871 | 5.16% | 44,565,208 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 4.33% | 1.89% | 5,430,000 | 320,000 | 6.26% | 25,358,100 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.34% | 1.79% | 1,680,000 | -90,000 | -5.08% | 7,845,600 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.86% | 1.11% | 2,330,000 | 100,000 | 4.48% | 10,881,100 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 6.39% | 0.89% | 8,005,000 | - | - | 37,383,350 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 2.25% | 0.88% | 2,817,505 | - | - | 13,157,748 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.92% | 0.72% | 1,148,307 | -706,456 | -38.09% | 5,362,594 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 0.18% | 0.64% | 227,470 | 7,470 | 3.40% | 1,062,285 | Jun 30, 2024 |
| RICHMOND BROTHERS, INC. | 0.05% | 0.57% | 61,827 | - | - | 288,732 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.01% | 0.52% | 1,269,714 | -295,202 | -18.86% | 5,929,564 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.82% | 0.50% | 2,286,135 | 333,278 | 17.07% | 10,676,250 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.54% | 0.43% | 674,268 | 55,239 | 8.92% | 3,148,832 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.26% | 0.28% | 320,727 | -135,861 | -29.76% | 1,497,795 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.24% | 0.22% | 1,555,004 | 57,086 | 3.81% | 7,261,869 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.48% | 0.22% | 600,000 | -750,000 | -55.56% | 2,661,900 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 0.81% | 0.12% | 1,009,500 | - | - | 4,714,365 | Jun 30, 2024 |
| PEREGRINE CAPITAL MANAGEMENT LLC | 0.58% | 0.10% | 731,048 | 731,048 | 100.00% | 3,413,994 | Jun 30, 2024 |
The largest Applied Therapeutics shareholder by % of total assets is PROPEL BIO MANAGEMENT, LLC. The company owns 6.57M shares of Applied Therapeutics (APLT), representing 19.89% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.24% | 0.00% | 6,569,787 | 5,580,510 | 564.10% | 30,680,905 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.25% | 0.00% | 5,322,460 | 2,312,170 | 76.81% | 24,855,889 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.87% | 0.00% | 2,343,483 | 1,721,256 | 276.63% | 10,944,066 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.67% | 0.00% | 2,098,815 | 1,494,387 | 247.24% | 9,802,702 | Jun 30, 2024 |
| STATE STREET CORP | 1.32% | 0.00% | 1,655,883 | 1,449,214 | 701.22% | 7,732,974,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 6.10% | 0.02% | 7,648,205 | 1,233,563 | 19.23% | 35,487,671 | Jun 30, 2024 |
| PEREGRINE CAPITAL MANAGEMENT LLC | 0.58% | 0.10% | 731,048 | 731,048 | 100.00% | 3,413,994 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 1.57% | 0.05% | 1,965,646 | 522,720 | 36.23% | 9,179,567 | Jun 30, 2024 |
| VR ADVISER, LLC | 7.61% | 2.84% | 9,542,871 | 467,871 | 5.16% | 44,565,208 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 5.24% | 19.89% | 6,567,858 | 455,952 | 7.46% | 30,671,897 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.82% | 0.50% | 2,286,135 | 333,278 | 17.07% | 10,676,250 | Jun 30, 2024 |
| MORGAN STANLEY | 2.81% | 0.00% | 3,519,737 | 325,685 | 10.20% | 16,437,171 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 4.33% | 1.89% | 5,430,000 | 320,000 | 6.26% | 25,358,100 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.23% | 0.00% | 283,793 | 283,793 | 100.00% | 1,325,311 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.22% | 0.00% | 271,613 | 271,613 | 100.00% | 1,268,432 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.22% | 0.00% | 277,277 | 252,773 | 1031.56% | 1,294,884 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.18% | 0.00% | 229,153 | 222,417 | 3301.92% | 1,070,000 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.16% | 0.05% | 197,042 | 197,042 | 100.00% | 920,186 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.18% | 0.00% | 229,862 | 194,317 | 546.68% | 1,073,457 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 1.76% | 3.03% | 2,211,320 | 194,304 | 9.63% | 10,326,864 | Jun 30, 2024 |
As of Jun 30 2024, Applied Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 5.58M stocks of APLT, valued at $30.68M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALYESKA INVESTMENT GROUP, L.P. | - | - | - | -4,000,000 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.04% | 0.00% | 50,000 | -1,431,006 | -96.62% | 233,500 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.43% | 0.02% | 533,729 | -1,302,913 | -70.94% | 2,492,514 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.09% | 0.00% | 110,908 | -815,517 | -88.03% | 517,940 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | - | - | - | -792,000 | -100.00% | - | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.48% | 0.22% | 600,000 | -750,000 | -55.56% | 2,661,900 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.92% | 0.72% | 1,148,307 | -706,456 | -38.09% | 5,362,594 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.12% | 0.00% | 152,449 | -562,759 | -78.68% | 711,937 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | 0.04% | - | 45,260 | -494,597 | -91.62% | 211,365 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 8.15% | 0.01% | 10,212,945 | -351,400 | -3.33% | 47,694,453 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.12% | 0.00% | 149,995 | -309,146 | -67.33% | 700,477 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.01% | 0.52% | 1,269,714 | -295,202 | -18.86% | 5,929,564 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -175,800 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.02% | 0.00% | 20,478 | -173,280 | -89.43% | 95,632 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -163,072 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -154,636 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -146,392 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 41,138 | -137,786 | -77.01% | 192,115 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.26% | 0.28% | 320,727 | -135,861 | -29.76% | 1,497,795 | Jun 30, 2024 |
As of Jun 30 2024, Applied Therapeutics's biggest institutional seller is ALYESKA INVESTMENT GROUP, L.P.. The company sold -4.00M shares of APLT, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PEREGRINE CAPITAL MANAGEMENT LLC | 0.58% | 0.10% | 731,048 | 731,048 | 100.00% | 3,413,994 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.22% | 0.00% | 271,613 | 271,613 | 100.00% | 1,268,432 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.16% | 0.05% | 197,042 | 197,042 | 100.00% | 920,186 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.09% | 0.00% | 114,619 | 114,619 | 100.00% | 535,271,000 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.07% | 0.00% | 89,131 | 89,131 | 100.00% | 416,242 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 51,723 | 51,723 | 100.00% | 242,064 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.03% | 0.00% | 38,900 | 38,900 | 100.00% | 182,000 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.03% | 0.00% | 36,824 | 36,824 | 100.00% | 171,968 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 32,568 | 32,568 | 100.00% | 152,093 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.02% | - | 30,270 | 30,270 | 100.00% | 141,361 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.02% | 0.00% | 24,578 | 24,578 | 100.00% | 114,779 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.02% | 0.00% | 23,476 | 23,476 | 100.00% | 110,000 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.01% | 0.00% | 18,567 | 18,567 | 100.00% | 87,000 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.04% | 17,210 | 17,210 | 100.00% | 80,371 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 17,137 | 17,137 | 100.00% | 79,737 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.01% | - | 12,200 | 12,200 | 100.00% | 57,218 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.01% | - | 11,583 | 11,583 | 100.00% | 54,093,000 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.01% | 0.00% | 11,494 | 11,494 | 100.00% | 53,677 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 9,419 | 9,419 | 100.00% | 43,987 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 6,966 | 6,966 | 100.00% | 32,531 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 3,326 | 3,326 | 100.00% | 16,000 | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | 0.00% | 0.00% | 203 | 203 | 100.00% | 948 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | 0.00% | - | 199 | 199 | 100.00% | 929 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | - | - | 5 | 5 | 100.00% | 24 | Jun 30, 2024 |
Applied Therapeutics's largest new institutional shareholder by number of shares is PEREGRINE CAPITAL MANAGEMENT LLC, purchased 731.05K shares, valued at $3.41M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALYESKA INVESTMENT GROUP, L.P. | - | - | - | -4,000,000 | -100.00% | - | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | - | - | - | -792,000 | -100.00% | - | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -175,800 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -163,072 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -154,636 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -146,392 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -98,879 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -92,872 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -64,700 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -60,795 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -47,356 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -40,070 | -100.00% | - | Jun 30, 2024 |
| RELYEA ZUCKERBERG HANSON LLC | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -39,631 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -37,145 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -33,600 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -30,100 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -28,013 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -27,017 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -25,826 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -22,200 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -11,300 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -10,658 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -10,400 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -10,261 | -100.00% | - | Jun 30, 2024 |
Applied Therapeutics's largest sold out institutional shareholder by shares sold is ALYESKA INVESTMENT GROUP, L.P., sold -4.00M shares, valued at -, as of undefined.
Applied Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Voya VARIABLE PRODUCTS TRUST | 0.12% | 42,298 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.10% | 867,854 | -707,800 | -44.92% | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.07% | 165,000 | -20,000 | -10.81% | Mar 28, 2024 |
| Simplify Exchange Traded Funds | 0.05% | 2,817,505 | 400,000 | 16.55% | Mar 28, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.04% | 2,427,436 | - | - | Feb 29, 2024 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.03% | 237,800 | - | - | Mar 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 85,658 | - | - | Mar 31, 2024 |
| ACAP Strategic Fund | 0.02% | 294,455 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.02% | 27,971 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.02% | 3,395 | - | - | Mar 28, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,701 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 28,179 | - | - | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 92,111 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,917,729 | -915,526 | -23.88% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 60,081 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 50,838 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 8,790 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 33,159 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,831 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 92,711 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 20,257 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 529,887 | 140,834 | 36.20% | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 7,224 | - | - | Feb 29, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 80,686 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 39,453 | 12,783 | 47.93% | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 17,876 | - | - | Dec 31, 2023 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 13,225 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 24,504 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 9,257 | - | - | Jan 31, 2024 |
| Meeder Funds | 0.00% | 2,426 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 84,290 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,179 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 4,986 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 2,464 | - | - | Aug 31, 2023 |
| RBB FUND, INC. | 0.00% | 33,900 | - | - | Feb 29, 2024 |
| BARON SELECT FUNDS | 0.00% | 3,591 | - | - | Mar 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 25,472 | - | - | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 11,832 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 112 | - | - | Apr 30, 2021 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 6,693 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,000 | - | - | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 22,066 | - | - | Jan 31, 2024 |
| AMG FUNDS III | 0.00% | 834 | - | - | Mar 28, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 349 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 660 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 4,849 | - | - | Jan 31, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 137,197 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 27,147 | - | - | Jan 31, 2024 |
| Victory Portfolios II | 0.00% | 4,371 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 9,547 | - | - | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,438 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 6,693 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 650 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 3,441 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 168 | - | - | Dec 31, 2023 |
| SPDR INDEX SHARES FUNDS | 0.00% | 7,376 | - | - | Mar 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 564 | - | - | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 116,056 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,407 | 2,296 | 108.76% | Jan 31, 2024 |
| ProFunds | 0.00% | 378 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 7,609 | 2,823 | 58.98% | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 59,681 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 110,816 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 94 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 6,564 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 6,900 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,362 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 105 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 500 | - | - | Mar 28, 2024 |
| PROSHARES TRUST | 0.00% | 4,038 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 17 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 14,374 | - | - | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,218 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 39,662 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 629 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 11,128 | - | - | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 3,823 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 3,389 | - | - | Feb 29, 2024 |
| FIDELITY HASTINGS STREET TRUST | 0.00% | 56,523 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 789 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 7,129 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 33,000 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 494 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 730 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 206 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 15,600 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 117 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 2,186 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 5,947 | 144 | 2.48% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 77,601 | 5,314 | 7.35% | Mar 31, 2024 |
| MFS SERIES TRUST X | 0.00% | 41,077 | - | - | Jan 31, 2024 |
| iShares U.S. ETF Trust | 0.00% | 391 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 895 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 7,400 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,457 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 126 | 106 | 530.00% | Jan 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 2,400 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 3,240 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,285 | 218 | 20.43% | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,266 | - | - | Mar 31, 2024 |
Applied Therapeutics's largest mutual fund holder by % of total assets is "Voya VARIABLE PRODUCTS TRUST", owning 42.30K shares, compromising 0.12% of its total assets.
Applied Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 91 | -9.00% |
| 31 Mar, 24 | 100 | 13.64% |
| 31 Dec, 23 | 88 | 57.14% |
| 30 Sep, 23 | 56 | 33.33% |
| 30 Jun, 23 | 42 | 23.53% |
| 31 Mar, 23 | 34 | -10.53% |
| 31 Dec, 22 | 38 | -5.00% |
| 30 Sep, 22 | 40 | -16.67% |
| 30 Jun, 22 | 48 | -31.43% |
| 31 Mar, 22 | 70 | - |
| 31 Dec, 21 | 70 | -1.41% |
| 30 Sep, 21 | 71 | 2.90% |
| 30 Jun, 21 | 69 | 2.99% |
| 31 Mar, 21 | 67 | -5.63% |
| 31 Dec, 20 | 71 | 9.23% |
| 30 Sep, 20 | 65 | -9.72% |
| 30 Jun, 20 | 72 | 16.13% |
| 31 Mar, 20 | 62 | 34.78% |
| 31 Dec, 19 | 46 | 53.33% |
| 30 Sep, 19 | 30 | 130.77% |
| 30 Jun, 19 | 13 | - |
As of 30 Jun 24, 91 institutions are holding Applied Therapeutics's shares, representing a decrease of -9.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 100,667,407 | 7.13% |
| 31 Mar, 24 | 93,965,703 | 53.04% |
| 31 Dec, 23 | 61,400,763 | 42.94% |
| 30 Sep, 23 | 42,956,794 | 36.52% |
| 30 Jun, 23 | 31,465,578 | 63.23% |
| 31 Mar, 23 | 19,277,269 | -2.04% |
| 31 Dec, 22 | 19,679,577 | -13.20% |
| 30 Sep, 22 | 22,672,096 | -15.21% |
| 30 Jun, 22 | 26,740,422 | 116.29% |
| 31 Mar, 22 | 12,363,316 | -17.15% |
| 31 Dec, 21 | 14,922,497 | -1.23% |
| 30 Sep, 21 | 15,109,069 | -1.68% |
| 30 Jun, 21 | 15,367,614 | 3.46% |
| 31 Mar, 21 | 14,854,263 | 22.71% |
| 31 Dec, 20 | 12,104,743 | -0.74% |
| 30 Sep, 20 | 12,194,843 | 3.41% |
| 30 Jun, 20 | 11,792,780 | 22.26% |
| 31 Mar, 20 | 9,646,017 | 93.15% |
| 31 Dec, 19 | 4,994,045 | 108.44% |
| 30 Sep, 19 | 2,395,913 | 9.09% |
| 30 Jun, 19 | 2,196,176 | - |
Applied Therapeutics (APLT) has 100.67M shares outstanding as of 30 Jun 24, up 7.13% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 80.33% | 1.43% |
| 31 Mar, 24 | 74.98% | 1.41% |
| 31 Dec, 23 | 72.88% | 3.25% |
| 30 Sep, 23 | 47.38% | 2.99% |
| 30 Jun, 23 | 39.81% | 3.40% |
| 31 Mar, 23 | 34.20% | 2.04% |
| 31 Dec, 22 | 40.95% | 1.84% |
| 30 Sep, 22 | 47.23% | 0.48% |
| 30 Jun, 22 | 99.40% | 4.47% |
| 31 Mar, 22 | 47.16% | 1.43% |
| 31 Dec, 21 | 57.45% | 1.72% |
| 30 Sep, 21 | 57.72% | 1.66% |
| 30 Jun, 21 | 58.92% | 1.56% |
| 31 Mar, 21 | 61.54% | 2.45% |
| 31 Dec, 20 | 50.15% | 1.70% |
| 30 Sep, 20 | 54.38% | 1.90% |
| 30 Jun, 20 | 53.45% | 2.50% |
| 31 Mar, 20 | 46.28% | 8.06% |
| 31 Dec, 19 | 23.96% | 12.20% |
| 30 Sep, 19 | 14.01% | 5.65% |
| 30 Jun, 19 | 15.75% | - |
As of 30 Jun 24, Applied Therapeutics is held by 80.33% institutional shareholders, representing a 1.43% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 59 | -13.24% |
| 31 Mar, 24 | 68 | 17.24% |
| 31 Dec, 23 | 58 | 70.59% |
| 30 Sep, 23 | 34 | 70.00% |
| 30 Jun, 23 | 20 | 25.00% |
| 31 Mar, 23 | 16 | 45.45% |
| 31 Dec, 22 | 11 | -35.29% |
| 30 Sep, 22 | 17 | -22.73% |
| 30 Jun, 22 | 22 | -33.33% |
| 31 Mar, 22 | 33 | -15.38% |
| 31 Dec, 21 | 39 | 25.81% |
| 30 Sep, 21 | 31 | -18.42% |
| 30 Jun, 21 | 38 | -9.52% |
| 31 Mar, 21 | 42 | 2.44% |
| 31 Dec, 20 | 41 | 32.26% |
| 30 Sep, 20 | 31 | -51.56% |
| 30 Jun, 20 | 64 | 33.33% |
| 31 Mar, 20 | 48 | 11.63% |
| 31 Dec, 19 | 43 | 86.96% |
| 30 Sep, 19 | 23 | 76.92% |
| 30 Jun, 19 | 13 | - |
59 institutional shareholders have increased their position in APLT stock as of 30 Jun 24 compared to 68 in the previous quarter (a -13.24% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | 31.25% |
| 31 Mar, 24 | 16 | 45.45% |
| 31 Dec, 23 | 11 | 57.14% |
| 30 Sep, 23 | 7 | -22.22% |
| 30 Jun, 23 | 9 | - |
| 31 Mar, 23 | 9 | -47.06% |
| 31 Dec, 22 | 17 | 54.55% |
| 30 Sep, 22 | 11 | -35.29% |
| 30 Jun, 22 | 17 | -15.00% |
| 31 Mar, 22 | 20 | 33.33% |
| 31 Dec, 21 | 15 | -11.76% |
| 30 Sep, 21 | 17 | 30.77% |
| 30 Jun, 21 | 13 | -7.14% |
| 31 Mar, 21 | 14 | -17.65% |
| 31 Dec, 20 | 17 | -15.00% |
| 30 Sep, 20 | 20 | 233.33% |
| 30 Jun, 20 | 6 | -45.45% |
| 31 Mar, 20 | 11 | 450.00% |
| 31 Dec, 19 | 2 | -50.00% |
| 30 Sep, 19 | 4 | - |
| 30 Jun, 19 | - | - |
21 institutional shareholders have reduced their position in APLT stock as of 30 Jun 24 compared to 16 in the previous quarter (a 31.25% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 91 | -9.00% | 100,667,407 | 7.13% | 80.33% | 1.43% | 59 | -13.24% | 21 | 31.25% |
| 31 Mar, 24 | 100 | 13.64% | 93,965,703 | 53.04% | 74.98% | 1.41% | 68 | 17.24% | 16 | 45.45% |
| 31 Dec, 23 | 88 | 57.14% | 61,400,763 | 42.94% | 72.88% | 3.25% | 58 | 70.59% | 11 | 57.14% |
| 30 Sep, 23 | 56 | 33.33% | 42,956,794 | 36.52% | 47.38% | 2.99% | 34 | 70.00% | 7 | -22.22% |
| 30 Jun, 23 | 42 | 23.53% | 31,465,578 | 63.23% | 39.81% | 3.40% | 20 | 25.00% | 9 | - |
| 31 Mar, 23 | 34 | -10.53% | 19,277,269 | -2.04% | 34.20% | 2.04% | 16 | 45.45% | 9 | -47.06% |
| 31 Dec, 22 | 38 | -5.00% | 19,679,577 | -13.20% | 40.95% | 1.84% | 11 | -35.29% | 17 | 54.55% |
| 30 Sep, 22 | 40 | -16.67% | 22,672,096 | -15.21% | 47.23% | 0.48% | 17 | -22.73% | 11 | -35.29% |
| 30 Jun, 22 | 48 | -31.43% | 26,740,422 | 116.29% | 99.40% | 4.47% | 22 | -33.33% | 17 | -15.00% |
| 31 Mar, 22 | 70 | - | 12,363,316 | -17.15% | 47.16% | 1.43% | 33 | -15.38% | 20 | 33.33% |
| 31 Dec, 21 | 70 | -1.41% | 14,922,497 | -1.23% | 57.45% | 1.72% | 39 | 25.81% | 15 | -11.76% |
| 30 Sep, 21 | 71 | 2.90% | 15,109,069 | -1.68% | 57.72% | 1.66% | 31 | -18.42% | 17 | 30.77% |
| 30 Jun, 21 | 69 | 2.99% | 15,367,614 | 3.46% | 58.92% | 1.56% | 38 | -9.52% | 13 | -7.14% |
| 31 Mar, 21 | 67 | -5.63% | 14,854,263 | 22.71% | 61.54% | 2.45% | 42 | 2.44% | 14 | -17.65% |
| 31 Dec, 20 | 71 | 9.23% | 12,104,743 | -0.74% | 50.15% | 1.70% | 41 | 32.26% | 17 | -15.00% |
| 30 Sep, 20 | 65 | -9.72% | 12,194,843 | 3.41% | 54.38% | 1.90% | 31 | -51.56% | 20 | 233.33% |
| 30 Jun, 20 | 72 | 16.13% | 11,792,780 | 22.26% | 53.45% | 2.50% | 64 | 33.33% | 6 | -45.45% |
| 31 Mar, 20 | 62 | 34.78% | 9,646,017 | 93.15% | 46.28% | 8.06% | 48 | 11.63% | 11 | 450.00% |
| 31 Dec, 19 | 46 | 53.33% | 4,994,045 | 108.44% | 23.96% | 12.20% | 43 | 86.96% | 2 | -50.00% |
| 30 Sep, 19 | 30 | 130.77% | 2,395,913 | 9.09% | 14.01% | 5.65% | 23 | 76.92% | 4 | - |
| 30 Jun, 19 | 13 | - | 2,196,176 | - | 15.75% | - | 13 | - | - | - |
Applied Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Applied Therapeutics's stock was made by Shendelman Shoshana on Aug 14 2024, selling 300,000 shares at $5.98 per share (valued at $1.79M).
Applied Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | 4 | 25.00% |
| Q2 2024 | 5 | 5 | 100.00% |
| Q1 2024 | - | 4 | - |
| Q4 2023 | 10 | 10 | 100.00% |
| Q3 2023 | 1 | 4 | 25.00% |
| Q2 2023 | 5 | - | - |
| Q1 2023 | 3 | 3 | 100.00% |
| Q4 2022 | 4 | - | - |
| Q3 2022 | 23 | 17 | 135.29% |
| Q2 2022 | 20 | 1 | 2000.00% |
| Q1 2022 | 13 | 3 | 433.33% |
| Q4 2021 | 12 | - | - |
| Q3 2021 | 6 | 20 | 30.00% |
| Q2 2021 | 21 | 38 | 55.26% |
| Q1 2021 | 16 | 43 | 37.21% |
| Q4 2020 | 9 | 36 | 25.00% |
| Q3 2020 | 3 | 23 | 13.04% |
| Q2 2020 | 14 | 48 | 29.17% |
| Q1 2020 | 9 | 6 | 150.00% |
| Q4 2019 | 3 | - | - |
1 total buy trades, and 4 total sell trades (buy/sell ratio of 0.25%) were made by Applied Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 3 | - |
| Q2 2024 | - | 5 | - |
| Q1 2024 | - | 4 | - |
| Q4 2023 | 1 | 7 | 14.29% |
| Q3 2023 | - | 3 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 3 | - |
| Q4 2022 | 3 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 8 | 1 | 800.00% |
| Q1 2022 | 3 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 2 | 11 | 18.18% |
| Q2 2021 | - | 21 | - |
| Q1 2021 | 2 | 25 | 8.00% |
| Q4 2020 | - | 18 | - |
| Q3 2020 | - | 16 | - |
| Q2 2020 | - | 38 | - |
| Q1 2020 | 2 | - | - |
| Q4 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Applied Therapeutics's stocks.
Applied Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| PMVP | PMV Pharmaceuticals, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| SEER | Seer, Inc. |
| BCAB | BioAtla, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| GANX | Gain Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| ORIC | ORIC Pharmaceuticals, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| LTRN | Lantern Pharma Inc. |
| INAB | IN8bio, Inc. |
| TFFP | TFF Pharmaceuticals, Inc. |
| VINC | Vincerx Pharma, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MOLN | Molecular Partners AG |
| LIFE | aTyr Pharma, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| STTK | Shattuck Labs, Inc. |
| GRTX | Galera Therapeutics, Inc. |
APLT Ownership FAQ
Who Owns Applied Therapeutics?
Applied Therapeutics is owned by institutional shareholders (80.33%), insiders (5.31%), and public (14.36%). The largest institutional shareholder of Applied Therapeutics is FRANKLIN RESOURCES INC (8.15% of total shares) and the top mutual fund owner is Voya VARIABLE PRODUCTS TRUST (0.12% of total shares).
Who are the major institutional shareholders of Applied Therapeutics?
Applied Therapeutics's major institutional shareholders are FRANKLIN RESOURCES INC, VR ADVISER, LLC, PERCEPTIVE ADVISORS LLC, JANUS HENDERSON GROUP PLC, and BLACKROCK INC.. The top five shareholders own together 33.50% of the company's share outstanding.
How many Applied Therapeutics shareholders are there?
As of Jun 2024, there are 91 institutional shareholders of Applied Therapeutics.
What percentage of Applied Therapeutics is owned by FRANKLIN RESOURCES INC?
FRANKLIN RESOURCES INC owns 10.21M shares of Applied Therapeutics, representing 8.15% of the company's total shares outstanding, valued at $47.69M (as of Jun 2024).
What percentage of Applied Therapeutics is owned by VR ADVISER, LLC?
As of Jun 2024, VR ADVISER, LLC holds 9.54M shares of Applied Therapeutics (APLT), compromising 7.61% of the company, valued at $44.57M.
What percentage of Applied Therapeutics is owned by PERCEPTIVE ADVISORS LLC?
PERCEPTIVE ADVISORS LLC is the third largest holder of Applied Therapeutics. The company owns 8M of the company's shares outstanding (worth $37.38M).